These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3234472)

  • 1. Dosage guidelines for the use of vancomycin based on its pharmacokinetics in infants.
    Lisby-Sutch SM; Nahata MC
    Eur J Clin Pharmacol; 1988; 35(6):637-42. PubMed ID: 3234472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.
    Asbury WH; Darsey EH; Rose WB; Murphy JE; Buffington DE; Capers CC
    Ann Pharmacother; 1993 Apr; 27(4):490-6. PubMed ID: 8477127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin pharmacokinetics in infants: relationship to postconceptional age and serum creatinine.
    Kildoo CW; Lin LM; Gabriel MH; Folli HL; Modanlou HD
    Dev Pharmacol Ther; 1989; 14(2):77-83. PubMed ID: 2630235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin pharmacokinetics and dosing in premature neonates.
    McDougal A; Ling EW; Levine M
    Ther Drug Monit; 1995 Aug; 17(4):319-26. PubMed ID: 7482683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of vancomycin in neonates of postconceptional age less than or equal to 32 weeks].
    Ginovart Galiana G; Mangues Bafalluy MA; Demestre Guasch X; Farré Riba R; Lopes Santos AP; Altirriba Valls O
    An Esp Pediatr; 1996 Aug; 45(2):167-71. PubMed ID: 8967647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.
    Ringenberg T; Robinson C; Meyers R; Degnan L; Shah P; Siu A; Sturgill M
    Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amikacin pharmacokinetics and suggested dosage modifications for the preterm infant.
    Kenyon CF; Knoppert DC; Lee SK; Vandenberghe HM; Chance GW
    Antimicrob Agents Chemother; 1990 Feb; 34(2):265-8. PubMed ID: 2327775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin pharmacokinetics in very low birth weight neonates.
    Leonard MB; Koren G; Stevenson DK; Prober CG
    Pediatr Infect Dis J; 1989 May; 8(5):282-6. PubMed ID: 2657617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical pharmacology of vancomycin in seriously ill preterm infants.
    Reed MD; Kliegman RM; Weiner JS; Huang M; Yamashita TS; Blumer JL
    Pediatr Res; 1987 Sep; 22(3):360-3. PubMed ID: 3658557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin pharmacokinetics in small, seriously ill infants.
    Naqvi SH; Keenan WJ; Reichley RM; Fortune KP
    Am J Dis Child; 1986 Feb; 140(2):107-10. PubMed ID: 3946318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring the treatment of sepsis with vancomycin in term newborn infants.
    Machado JK; Feferbaum R; Diniz EM; Okay TS; Ceccon ME; Costa Vaz FA
    Rev Hosp Clin Fac Med Sao Paulo; 2001; 56(1):17-24. PubMed ID: 11378679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of a gentamicin dosing protocol based on postconceptional age: comparison to published neonatal guidelines.
    Lopez-Samblas AM; Torres CL; Wang H; Feuer WJ; Goldberg RN
    Ann Pharmacother; 1992 Apr; 26(4):534-8. PubMed ID: 1576392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin pharmacokinetics and dose recommendations for preterm infants.
    James A; Koren G; Milliken J; Soldin S; Prober C
    Antimicrob Agents Chemother; 1987 Jan; 31(1):52-4. PubMed ID: 3566238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simulation of vancomycin peak and trough concentrations using five dosing methods in 37 patients.
    Zokufa HZ; Rodvold KA; Blum RA; Riff LJ; Fischer JH; Crossley KB; Rotschafer JC
    Pharmacotherapy; 1989; 9(1):10-6. PubMed ID: 2922356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin pharmacokinetics in infants: relationships to indices of maturation.
    Schaible DH; Rocci ML; Alpert GA; Campos JM; Paul MH; Polin RA; Plotkin SA
    Pediatr Infect Dis; 1986; 5(3):304-8. PubMed ID: 3725640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram based on actual body weight for estimation of vancomycin maintenance dose in infants.
    Pokorná P; Šíma M; Černá O; Slanař O
    Infect Dis (Lond); 2019 May; 51(5):334-339. PubMed ID: 30950674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influences of renal function and maturation on vancomycin elimination in newborns and infants.
    Capparelli EV; Lane JR; Romanowski GL; McFeely EJ; Murray W; Sousa P; Kildoo C; Connor JD
    J Clin Pharmacol; 2001 Sep; 41(9):927-34. PubMed ID: 11549096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin: pharmacokinetics and administration regimens in neonates.
    de Hoog M; Mouton JW; van den Anker JN
    Clin Pharmacokinet; 2004; 43(7):417-40. PubMed ID: 15139793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kinetic profile of vancomycin in neonates.
    Silva R; Reis E; Bispo MA; Almeida AM; Costa IM; Falcão F; Palminha JM; Falcão AC
    J Pharm Pharmacol; 1998 Nov; 50(11):1255-60. PubMed ID: 9877311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.